Page last updated: 2024-12-08

2-amino-3,3-dimethylbutanoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

tert-butylglycine : A glycine derivative that is glycine with a tertiary butyl group at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
GlycinegenusA non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.[MeSH]FabaceaeThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH]

Cross-References

ID SourceID
PubMed CID306131
CHEBI ID72770
SCHEMBL ID6688
MeSH IDM0237569

Synonyms (72)

Synonym
tert-butylglycine
nsc-203785
nsc203785
dl-tert-leucine, 98%
33105-81-6
dl-tert-leucine
AKOS000263225
2-amino-3,3-dimethylbutanoic acid
FT-0657029
h-tle-oh
A5914
2-amino-3,3-dimethyl-butyric acid;t-butylglycine
2-amino-3,3-dimethyl-butyric acid
t-butylglycine
EN300-73664
A818600
3-methyl valine
3-methylvaline
dl-tert-butylglycine
tert-leucine
CHEBI:72770
h-dl-tle-oh
FT-0625623
FT-0625515
FT-0628020
AM20090501
AB02673
AB02564
AB00342
NPDBDJFLKKQMCM-UHFFFAOYSA-N
(dl)-tert-leucine
AKOS016052444
SCHEMBL6688
dl-terleucine
unii-ps3vjy8xhi
dl-tert-butyl-glycine
psi-leucine
pseudoleucine
dl-pseudoleucine
ps3vjy8xhi ,
mfcd00004265
mfcd00064218
SY005401
mfcd00065933
SY005391
SY005390
pseudoleucin
J-300340
Q-102255
AC-24097
F0001-0747
DTXSID90197039
CS-W002302
DTXSID00308412
h-tbu-dl-gly-oh
dl-2-(tert-butyl)glycine
BCP15485
BCP04717
Q27140135
2-amino-3,3-dimethylbutyric acid
AS-13124
dl-2-amino-3,3-dimethylbutanoic acid
intermediates of atazanavir
3-methyl-dl-valine
dl-valine, 3-methyl-
dl-tert-butylglycine dl-tert-leucine
1-benzyl-4-oxo-piperidine-3-carboxylicacid
2-amino-3,3-dimethylbutanoicacid
(+/-)-2-amino-3,3-dimethylbutyric acid, dl-alpha-tert-butylglycine
2-amino-3,3-dimethyl butyric acid
HY-W002302
PD196039
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
non-proteinogenic alpha-amino acidAny alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.26)18.7374
1990's1 (5.26)18.2507
2000's7 (36.84)29.6817
2010's9 (47.37)24.3611
2020's1 (5.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]